Paper24251583
Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury.
Ryu JK and 5 others. J Sex Med, 2014. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury. Papers, record 24251583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24251583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erectile Dysfunction | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Penile Erection | Major topic |
| Penis | Major topic |
| Peripheral Nerve Injuries | Major topic |
| Animals | |
| Cell Differentiation | |
| Cell Separation | |
| Disease Models, Animal | |
| Injections | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Muscle, Smooth | |
| Nitric Oxide Synthase Type I | |
| Regeneration |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40241900 | Advances in stem cell therapy for erectile dysfunction: preclinical evidence and emerging therapeutic approaches. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40241900 | PubMed |
| 37382278 | Adipose Derived Mesenchymal Stem Cells-Derived Mitochondria Transplantation Ameliorated Erectile Dysfunction Induced by Cavernous Nerve Injury. | World J Mens Health | 2024 | https://conductscience.org/library/papers/37382278 | PubMed |
| 36836859 | Stem Cell Therapy for Erectile Dysfunction: A Step towards a Future Treatment. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36836859 | PubMed |
| 35337262 | Lipopolysaccharide-preconditioned allogeneic adipose-derived stem cells improve erectile function in a rat model of bilateral cavernous nerve injury. | Basic Clin Androl | 2022 | https://conductscience.org/library/papers/35337262 | PubMed |
| 33419152 | Erectile Dysfunction Treatment Using Stem Cells: A Review. | Medicines (Basel) | 2021 | https://conductscience.org/library/papers/33419152 | PubMed |
| 33009701 | Exosomes derived from smooth muscle cells ameliorate diabetes-induced erectile dysfunction by inhibiting fibrosis and modulating the NO/cGMP pathway. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/33009701 | PubMed |
| 32438565 | Revisiting the Regenerative Therapeutic Advances Towards Erectile Dysfunction. | Cells | 2020 | https://conductscience.org/library/papers/32438565 | PubMed |
| 31943490 | Co-overexpression of VEGF and GDNF in adipose-derived stem cells optimizes therapeutic effect in neurogenic erectile dysfunction model. | Cell Prolif | 2020 | https://conductscience.org/library/papers/31943490 | PubMed |
| 31899688 | Endothelial progenitor cells promote viability and nerve regenerative ability of mesenchymal stem cells through PDGF-BB/PDGFR-β signaling. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/31899688 | PubMed |
| 31588222 | Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury. | Theranostics | 2019 | https://conductscience.org/library/papers/31588222 | PubMed |
| 31257465 | Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats. | Int J Mol Med | 2019 | https://conductscience.org/library/papers/31257465 | PubMed |
| 30367131 | The mechanisms and potential of stem cell therapy for penile fibrosis. | Nat Rev Urol | 2019 | https://conductscience.org/library/papers/30367131 | PubMed |
| 30257719 | MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury. | Stem Cell Res Ther | 2018 | https://conductscience.org/library/papers/30257719 | PubMed |
| 28053944 | The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review. | World J Mens Health | 2016 | https://conductscience.org/library/papers/28053944 | PubMed |
| 27398139 | Periprostatic implantation of neural differentiated mesenchymal stem cells restores cavernous nerve injury-mediated erectile dysfunction. | Am J Transl Res | 2016 | https://conductscience.org/library/papers/27398139 | PubMed |
| 25874038 | Prospects of stem cell treatment in benign urological diseases. | Korean J Urol | 2015 | https://conductscience.org/library/papers/25874038 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24251583
GET https://conductscience.org/api/papers/v1/24251583/authors